Information scientifique avancée
La Clínica Universidad de Navarra participa en un ensayo clínico promovido por la compañía farmacéutica Merus que probará la seguridad y eficacia de un fármaco experimental diseñado de forma específica contra una fusión genética en el cáncer de pulmón...
Lire la suite/image%2F1572350%2F20210621%2Fob_63ed8e_57922724-7.png)
SARS-CoV-2 Delta variant, also known as lineage B.1.617.2, is a variant of lineage B.1.617 of SARS-CoV-2, the virus that causes COVID-19.[1] It was first detected in India in late 2020.[2][3] The World Health Organization (WHO) named it the Delta variant...
Lire la suite/image%2F1572350%2F20210621%2Fob_c81f25_115787430-gettyimages-1229654108.jpg)
Va ccinated with study intervention produced by manufacturing “Process 1” will be selected for this descriptive analysis. Participants are expected to participate for up to a maximum of approximately 26 months. The duration of study follow-up may be shorter...
Lire la suite/image%2F1572350%2F20210619%2Fob_a07fb3_image.jpeg)
79 B cell epitopes were identified on the structural proteins S, M, N, the polyprotein orf1ab, and the accessory proteins orf3a, orf6, and orf8. The highest ranking epitope was 1-M-24, which is found at the N-terminal end of M. The patients' sera showed...
Lire la suite/image%2F1572350%2F20210619%2Fob_f1d377_440px-ivermectin-skeletal-svg-2.png)
SARS-CoV-2 Editar La ivermectina tiene efectos antivirales contra varios virus de ARN monocatenario de sentido positivo distintos, incluido el SARS-CoV-2.[16] La ivermectina inhibe la replicación de SARS-CoV-2 en cultivo de células de riñón de mono con...
Lire la suite/image%2F1572350%2F20210619%2Fob_31acbb_0001-6002-amc-62-02-57-gf1.jpg)
Hydroxychloroquine accumulation in human organelles also raise their pH, which inhibits antigen processing, prevents the alpha and beta chains of the major histocompatibility complex (MHC) class II from dimerizing, inhibits antigen presentation of the...
Lire la suite